A twice-yearly injection may soon change how high blood pressure is treated. In a global trial, patients receiving the experimental drug zilebesiran alongside standard therapy saw greater blood pressure reductions than those on standard treatment alone. The drug works by blocking a key liver protein, helping blood vessels relax. Researchers say this long-lasting approach could make it much easier for patients to keep their condition under control.
source https://www.sciencedaily.com/releases/2026/04/260411022035.htm
Linux 7.0 debuts as Linus Torvalds ponders AI's bug-finding powers and
their impact on release process
-
Makes Rust support official, adds code for ancient Alpha and SPARC CPUs
Linus Torvalds has released version 7.0 of the Linux kernel.…
source
https://go....
11 hours ago
No comments:
Post a Comment